Acriptega 50mg/300mg/300mg (90 Tablets) – HIV-1 Management
Acriptega is a fixed-dose combination antiretroviral medication used for the treatment of HIV-1 infection in adults and adolescents. Often referred to as the TLD regimen, it combines three active ingredients into a single, once-daily pill to simplify treatment and improve long-term outcomes.
The 90-tablet pack is specifically designed for multi-month dispensing, providing a convenient 3-month supply for consistent viral suppression.
Key Active Ingredients
Acriptega contains:
- Dolutegravir (50mg): An integrase inhibitor that prevents the virus from replicating.
- Lamivudine (300mg): A nucleoside reverse transcriptase inhibitor (NRTI).
- Tenofovir Disoproxil Fumarate (300mg): A nucleotide reverse transcriptase inhibitor (NtRTI).
Benefits of Acriptega
- Simplified Dosing: One tablet daily reduces pill burden.
- Effective Suppression: Helps lower HIV viral load to undetectable levels.
- Immune Support: Aids in maintaining or improving CD4 cell counts.
- 3-Month Supply: The 90s pack size reduces the frequency of pharmacy visits.
Usage and Administration
Take one tablet daily, with or without food, at the same time each day. It is essential to follow the dosage prescribed by your healthcare provider. Do not skip doses, as consistency is key to preventing drug resistance.
Acriptega is suitable for adults and adolescents weighing at least 40kg. Always consult a GoMed pharmacist or your doctor before starting or switching HIV medications.
Important Storage Information
Keep the bottle tightly closed to protect the tablets from moisture. Store in a cool, dry place and do not remove the desiccant (drying agent) from the bottle.